However, it can be challenging because of asynchronous multiglandular involvement, related to higher rates of recurrent hypercalcemia (approximately 20%-60% of MEN1 patients, compared to only 4% sporadic PHPT patients (153, 154)). This evidence concerns the gene MEN1 and Hypercalcemia.